ArticleInflammation2026
IRGM1-IRF7 Axis Controls Macrophage Chemotaxis to Orchestrate Skeletal Muscle Regeneration.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Efficient skeletal muscle regeneration requires precise orchestration of immune cells. The timely recruitment of macrophages is particularly critical, linking inflammation resolution with repair initiation. However, the intrinsic molecular switches governing this process remain elusive. Here, we identify the Immunity-related GTPase family M1 protein (IRGM1) as a central regulator of macrophage-mediated muscle repair. IRGM1 is dynamically upregulated post-injury, with expression kinetics paralleling macrophage infiltration. Using myeloid-specific knockout mice, we demonstrate that macrophage-derived IRGM1 is essential for skeletal muscle regeneration. Its absence results in persistent inflammation, delayed regeneration, and impaired functional recovery. Mechanistically, IRGM1 cell-autonomously governs the intrinsic chemotactic capacity of macrophages. IRGM1 deficiency disrupts the response to damage signals by impairing the inducible expression of key chemokine receptors, including CCR1, CCR2, and CCR5. We further show that IRGM1 functions by negatively regulating the transcription factor Interferon regulatory factor 7 (IRF7). IRF7 abnormally accumulates in IRGM1-deficient macrophages, suppressing their migratory capacity. Notably, IRF7 knockdown rescues this migratory defect. Our results define a novel IRGM1-IRF7 signaling axis that controls the spatiotemporal dynamics of macrophages during muscle repair. By relieving IRF7-mediated suppression of migration, this axis ensures coordinated skeletal muscle regeneration. Our findings thus provide both a new mechanistic rationale and a potential therapeutic target for regenerative disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.